- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Maha FDA shortlists 59 pharmacists for selling Remdesivir
Mumbai: The Maharashtra government on Friday came out with a list of 59 pharmacists in the state where Remdesivir, a drug used for COVID-19 treatment, will be available at Rs 2,360 per unit.Principal secretary of the public health department Dr Pradeep Vyas informed district collectors and municipal commissioners about the decision in a letter."The medicine is administered free of cost at...
Mumbai: The Maharashtra government on Friday came out with a list of 59 pharmacists in the state where Remdesivir, a drug used for COVID-19 treatment, will be available at Rs 2,360 per unit.
Principal secretary of the public health department Dr Pradeep Vyas informed district collectors and municipal commissioners about the decision in a letter.
"The medicine is administered free of cost at state- run hospitals, however, there was no cap on its price at private hospitals.
"(Now) The pharmaceutical shops in every district and city are designated for its supply, which will ensure smooth supply of the medicine to every patient," Vyas said in the letter.
Read also: Gilead, European Commission Ink Pact For 500000 Treatment Courses Of Remdesivir Against COVID-19
"The Food and Drug Administration has shortlisted the pharmaceutical outlets in the state. There are five outlets in Mumbai division, 13 in Pune division, nine in Nashik, 11 in Aurangabad, 10 in Konkan, six in Nagpur and five in Amravati," the letter said.
Read also: FDA approves remdesivir for treating hospitalized COVID-19 patients
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751